Generics sign patent pool pledge to improve access to COVID-19 treatments

In response to the surge of COVID-19 infections worldwide, 18 generic drug makers have pledged to join the effort by the Medicines Patent Pool (MPP) to accelerate global access to effective COVID-19 treatments via a pool for voluntary product licences.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Africa

WHO launches COVID-19 pool with 37 countries

29 May 2020 The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

26 March 2020 The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

More on this story

Africa

WHO launches COVID-19 pool with 37 countries

29 May 2020 The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

More on this story

Africa

WHO launches COVID-19 pool with 37 countries

29 May 2020 The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool